News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • EIA raised global oil supply forecasts after the Strait of Hormuz reopened, trimming Brent and U.S. gasoline price projections.
  • CoreWeave shows weakening technicals and competitive pressure, prompting a tactical short setup targeting $68.
  • Brazilian senator urged the U.S. to drop a proposed 25% tariff on Brazilian imports ahead of the USTR's July 15 decision.
  • JPMorgan says a SpaceX-Tesla merger offers strategic benefits but would confront significant regulatory and governance hurdles.
  • Hugo Boss saw rapid sell-outs of Pochettino's blue shirt, boosting retail demand while the company's shares stay under pressure.
  • Prosecutors played video placing a suspect on a rooftop in the Charlie Kirk shooting as they seek to bind him over for trial.

Latest Articles

Goldman Sees PJM Tightness Lifting Power Prices; Starts Talen at Buy

Goldman Sees PJM Tightness Lifting Power Prices; Starts Talen at Buy

Goldman Sachs began coverage of two large U.S. independent power producers, arguing that structural tightness in the PJM regional grid - exacerbated by data-center demand and thermal plant retirements - will support elevated power and capacity prices and boost earnings into the late 2020s. The bank initiated Talen Energy with a Buy rating and a $49…

Rescue Teams in Nabatieh Sift Through Rubble After Civil Defence HQ Destroyed

Rescue Teams in Nabatieh Sift Through Rubble After Civil Defence HQ Destroyed

Rescue personnel in Nabatieh have been combing the wreckage of their civil defence headquarters after it was obliterated by an airstrike late last month. The destruction has deprived first responders of their base of operations and archives, compounded by multiple casualties among civil defence members and extensive damage across the city amid mont…

Monness Raises Salesforce to Buy, Citing Valuation and AI Resilience

Monness Raises Salesforce to Buy, Citing Valuation and AI Resilience

Monness, Crespi, Hardt moved Salesforce from Neutral to Buy, with analyst Brian White assigning a 12-month price target of $200. The firm argues that concerns about generative AI undermining Salesforce are overstated and highlights recent product traction and ARR growth as reasons the company can navigate the AI transition.

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)

Longeveron Inc., a clinical-stage biotech company focusing on stem cell therapies, announced that additional analysis from its Phase 2a trial of laromestrocel in mild Alzheimer's disease has been accepted for presentation at the 2026 Alzheimer’s Association International Conference. The data supports the therapeutic potential of laromestrocel and e…

Wall Street Lifts Micron Price Targets as Data-Center Memory Demand Tightens

Wall Street Lifts Micron Price Targets as Data-Center Memory Demand Tightens

A wave of aggressive model revisions from major research firms has pushed Micron Technology's stock targets into the $1,200 to $1,500 range as demand for high-bandwidth memory and conventional DRAM outpaces industry supply. Analysts cite outsized pricing power, sold-out HBM capacity under binding contracts through 2026 and into 2027, and manufactur…

Tesla's Hidden Lift from SpaceX: A Trade to Ride the Musk Network Effect

Tesla's Hidden Lift from SpaceX: A Trade to Ride the Musk Network Effect

Tesla ($TSLA) is trading at $389.95 with a market cap near $1.46T, rich multiples (P/E ~362, P/S ~15.2) and modest near-term momentum. SpaceX's blockbuster IPO and $2.1T market cap create actionable cross-company catalysts - Starlink connectivity for cars, AI infrastructure spend, chip and manufacturing partnerships, and shared energy solutions - t…

Sezzle: Profitable BNPL Growth with Momentum — A Measured Long Idea

Sezzle: Profitable BNPL Growth with Momentum — A Measured Long Idea

Sezzle has moved from a niche BNPL player to a profitable, cash-generative fintech with clear growth vectors. The stock is up sharply but fundamentals back the rally: healthy free cash flow, high ROE and accelerating subscriber/revenue growth. This trade targets a mid-term (45 trading days) push toward a new cycle high while protecting capital with…

Buy SMCI Into the Dilution Panic - AI Order Book Still the Main Event

Buy SMCI Into the Dilution Panic - AI Order Book Still the Main Event

Super Micro's stock has been punished after a $7 billion equity financing to fund component purchases for an enormous AI server backlog. The headline dilution is real and messy, but the company's order book, current valuation, and tradeable technicals create a high-expected-value long opportunity if you size and stop properly. This idea lays out en…

Odysight.ai® Receives Purchase Order from Honeywell Aerospace APU Division to Launch Proof of Concept of Odysight.ai's Advanced Predictive Maintenance Vision-Based Monitoring System on Honeywell Aerospace Auxiliary Power Units Portfolio

Odysight.ai® Receives Purchase Order from Honeywell Aerospace APU Division to Launch Proof of Concept of Odysight.ai's Advanced Predictive Maintenance Vision-Based Monitoring System on Honeywell Aerospace Auxiliary Power Units Portfolio

Odysight.ai has secured a purchase order from Honeywell Aerospace APU Division for a proof-of-concept deployment of its advanced visual sensing and AI-driven predictive maintenance platform. The collaboration will initially focus on monitoring the air intake of Honeywell's Auxiliary Power Units to improve fault detection, reduce unplanned downtime,…

Xometry Expands Injection Molding Platform with a Wider Selection of Materials, On-Demand Expert Access and One-Click Reordering

Xometry Expands Injection Molding Platform with a Wider Selection of Materials, On-Demand Expert Access and One-Click Reordering

Xometry, Inc. (NASDAQ: XMTR) announced new features for its injection molding platform, including an expanded catalog of materials, free on-demand Design for Manufacturability consultations, and a one-click reordering system that streams orders to original suppliers. These enhancements aim to improve design accuracy, speed, and procurement efficien…

IREN Shares Climb After Jefferies Starts Coverage With Buy Rating

IREN Shares Climb After Jefferies Starts Coverage With Buy Rating

IREN Ltd shares rose about 5% in premarket trading after Jefferies began coverage with a Buy rating and a $79.00 price target. Jefferies analyst Jonathan Petersen pointed to IREN's roughly 6 GW powered land bank, vertically integrated GPU cloud model and large contracts with Microsoft and NVIDIA as foundational to an expected $3.1 billion in annual…

Insider Moves Wednesday: Star Equity and Airbnb Among Notable Trades

Insider Moves Wednesday: Star Equity and Airbnb Among Notable Trades

Wednesday’s SEC disclosures show a mix of insider purchases and large sales across U.S. equities. CEO and directors increased stakes at Star Equity Holdings and Franklin BSP Realty Trust, while executives and major shareholders at Applied Materials, Arista Networks, Airbnb, Ingram Micro and Clearwater Analytics executed substantial dispositions. Sm…

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

AIM ImmunoTech announced that the final subject has received their first dose in the Phase 2 DURIPANC clinical trial evaluating Ampligen in combination with Imfinzi for metastatic pancreatic cancer. The trial's primary endpoint analysis is expected to start in December 2026 with topline results anticipated in Q1 2027. The company aims to use explor…

Flotek (FTK): A Growth Re-Rate Trade Waiting for Execution

Flotek (FTK): A Growth Re-Rate Trade Waiting for Execution

Flotek has built a high-return niche combining green specialty chemicals and real-time data analytics for oilfield customers. Recent top-line acceleration and solid ROE argue for upside, but the market is pricing in execution — and the short base is large. This is a medium-risk swing trade that bets on continued revenue momentum and margin improvem…

Luda Technology Group Limited Signed MOU to Acquire 55% Shares in Asia AI Data Centre & Quantum Technology Company Limited, Marking Strategic Entry into Data Centre and AI Computing Infrastructure Industry

Luda Technology Group Limited Signed MOU to Acquire 55% Shares in Asia AI Data Centre & Quantum Technology Company Limited, Marking Strategic Entry into Data Centre and AI Computing Infrastructure Industry

Luda Technology Group Limited (NYSE: LUD), traditionally a manufacturer and trader of steel flanges and fittings, has signed a memorandum of understanding to acquire a 55% stake in Asia AI Data Centre & Quantum Technology Company Limited. This acquisition strategically positions Luda Technology to enter the growing data centre and AI computing infr…